See Tai Sandi (CIK 2009350) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-11-20). Recent activity: Sell LXEO (386 shares), Buy LXEO (10,890 shares), Sell LXEO (3,844 shares), Sell LXEO (44 shares), Sell LXEO (382 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-20 | Lexeo Therapeutics, Inc. (LXEO) | Chief Development Officer | Sell | 386 | $3,578 |
| 2025-10-17 | Lexeo Therapeutics, Inc. (LXEO) | Chief Development Officer | Buy | 10,890 | $0 |
| 2025-10-17 | Lexeo Therapeutics, Inc. (LXEO) | Chief Development Officer | Sell | 3,844 | $34,365 |
| 2025-10-17 | Lexeo Therapeutics, Inc. (LXEO) | Chief Development Officer | Sell | 44 | $421 |
| 2025-08-20 | Lexeo Therapeutics, Inc. (LXEO) | Chief Development Officer | Sell | 382 | $1,784 |
| 2025-05-20 | Lexeo Therapeutics, Inc. (LXEO) | Chief Development Officer | Sell | 367 | $1,017 |
| 2025-04-09 | Lexeo Therapeutics, Inc. (LXEO) | Chief Development Officer | Buy | 5,720 | $14,929 |
| 2025-02-21 | Lexeo Therapeutics, Inc. (LXEO) | Chief Development Officer | Sell | 1,486 | $6,553 |
Source: SEC Form 4 filings · as of 2025-11-20